Medtronic plc — Director's Dealing 2017

Mar 6, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2017-03-02

Reporting Person: HAKAMI HOOMAN (EVP & Group President Diabetes)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-02	Ordinary Shares	M	14871	$62.76	Acquired	73800	Direct
2017-03-02	Ordinary Shares	M	797	$62.76	Acquired	74597	Direct
2017-03-02	Ordinary Shares	M	36648	$62.76	Acquired	111245	Direct
2017-03-02	Ordinary Shares	S	52316	$82.327	Disposed	58929	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-02	Stock Option (Right to Buy)	$62.76	M	14871	Disposed	2024-07-28	Ordinary Shares (14871)	Direct
2017-03-02	Stock Option (Right to Buy)	$62.76	M	797	Disposed	2024-07-28	Ordinary Shares (797)	Direct
2017-03-02	Stock Option (Right to Buy)	$62.76	M	36648	Disposed	2024-07-28	Ordinary Shares (36648)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.30 to $82.41, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2: This balance increased by 627 shares due to exempt transactions such as dividend reinvestment.

F3: This option to purchase 29,743 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 29,743 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F4: This option to purchase 1,594 ordinary shares of New Medtronic for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F5: This option to purchase 73,296 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 73,296 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.